专家一致认为,在接受口服抗血栓治疗的患者中,切除牙的术后管理是必要的
Jian Pan1, Yang Xue2, Jihong Zhao3
1State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Oral Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
概括
接受抗血栓药物治疗的患者在拔牙时面临出血风险. 这种共识为在手术期间管理这些风险提供了指导,以获得更好的患者结果.
科学领域:
- 口腔和牙面部外科手术
- 心脏病学 心脏病学
- 血液学 血液学 血液学
背景情况:
- 血栓栓塞栓性疾病是全球主要的死亡原因.
- 抗血栓药物对于治疗血栓形成至关重要,但会增加手术出血的风险.
- 拔牙是一种常见的口腔外科手术程序,对于服用抗血栓剂的患者来说,具有特定的管理挑战.
研究的目的:
- 为在口服抗血栓药物时接受拔牙的患者的术后管理提供专家共识.
- 为了澄清手术前出血风险评估,手术内手术和术后护理.
- 提高临床医生的知识和标准化管理协议.
主要方法:
- 开发口腔外科,心脏病学和血液学专家的一致声明.
- 专注于基于证据的指导方针和临床最佳实践.
- 结构化建议涵盖风险评估,手术技术和手术后护理.
主要成果:
- 确定在拔牙期间服用抗血栓药物的患者出血的关键危险因素.
- 定义了外科手术期间的管理策略,包括手术前评估,手术内静血技术和术后监测.
- 强调避免不必要的药物戒断和有效管理出血风险.
结论:
- 在服用口服抗血栓剂的患者中,标准化的术后管理对于安全拔牙至关重要.
- 积极主动地对出血风险进行评估和管理,可以提高患者的安全性.
- 这种共识旨在减少混乱,并改善这种患者群体的临床实践.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:26Tonsillitis II: Management
110
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
110
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
689
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
689
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
01:15Teeth
404
The formation of teeth, also known as odontogenesis, is a complex process that begins in utero, around the sixth week of embryonic development. There are three stages to this process: the bud stage, the cap stage, and the bell stage.
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin...
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin...
404